As of 2025-07-06, the EV/EBITDA ratio of Titan Pharmaceuticals Inc (TTNP) is -0.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TTNP's latest enterprise value is 2.06 mil USD. TTNP's TTM EBITDA according to its financial statements is -5.89 mil USD. Dividing these 2 quantities gives us the above TTNP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-06-27 | -0.35 |
| 2025-06-26 | -0.35 |
| 2025-06-25 | -0.36 |
| 2025-06-24 | -0.35 |
| 2025-06-23 | -0.36 |
| 2025-06-20 | -0.33 |
| 2025-06-18 | -0.34 |
| 2025-06-17 | -0.35 |
| 2025-06-16 | -0.32 |
| 2025-06-13 | -0.36 |
| 2025-06-12 | -0.36 |
| 2025-06-11 | -0.37 |
| 2025-06-10 | -0.39 |
| 2025-06-09 | -0.37 |
| 2025-06-06 | -0.39 |
| 2025-06-05 | -0.43 |
| 2025-06-04 | -0.41 |
| 2025-06-03 | -0.41 |
| 2025-06-02 | -0.42 |
| 2025-05-30 | -0.38 |
| 2025-05-29 | -0.38 |
| 2025-05-28 | -0.38 |
| 2025-05-27 | -0.39 |
| 2025-05-23 | -0.34 |
| 2025-05-22 | -0.38 |
| 2025-05-21 | -0.36 |
| 2025-05-20 | -0.34 |
| 2025-05-19 | -0.35 |
| 2025-05-16 | -0.39 |
| 2025-05-15 | -0.42 |
| 2025-05-14 | -0.41 |
| 2025-05-13 | -0.37 |
| 2025-05-12 | -0.48 |
| 2025-05-09 | -0.46 |
| 2025-05-08 | -0.49 |
| 2025-05-07 | -0.29 |
| 2025-05-06 | -0.26 |
| 2025-05-05 | -0.26 |
| 2025-05-02 | -0.25 |
| 2025-05-01 | -0.26 |
| 2025-04-30 | -0.25 |
| 2025-04-29 | -0.22 |
| 2025-04-28 | -0.26 |
| 2025-04-25 | -0.24 |
| 2025-04-24 | -0.26 |
| 2025-04-23 | -0.24 |
| 2025-04-22 | -0.23 |
| 2025-04-21 | -0.22 |
| 2025-04-17 | -0.25 |
| 2025-04-16 | -0.25 |